Cargando…
Vaccination and infection prevention in inflammatory bowel disease
The current medical therapy used in Crohn’s disease and ulcerative colitis comprises drugs that interfere with immune response and therefore caution is needed for infectious side effects, and where possible, strategies to prevent their occurrence should be undertaken. Last year, international consen...
Autores principales: | Vermeire, Severine, Van Assche, Gert, Rutgeerts, Paul |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Faculty of 1000 Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2998810/ https://www.ncbi.nlm.nih.gov/pubmed/21170370 http://dx.doi.org/10.3410/M2-80 |
Ejemplares similares
-
Adalimumab in Crohn’s disease
por: Van Assche, Gert, et al.
Publicado: (2007) -
New treatment options for inflammatory bowel diseases
por: Verstockt, Bram, et al.
Publicado: (2018) -
Infliximab: the evidence for its place in therapy in ulcerative colitis
por: Van Assche, Gert, et al.
Publicado: (2007) -
Mucosal Gene Expression of Antimicrobial Peptides in Inflammatory Bowel Disease Before and After First Infliximab Treatment
por: Arijs, Ingrid, et al.
Publicado: (2009) -
The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile
por: Bollen, Lize, et al.
Publicado: (2015)